Market closedNon-fractional

Clearside Biomedical/CLSD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Clearside Biomedical

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Ticker

CLSD

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Alpharetta, United States

Employees

30

CLSD Metrics

BasicAdvanced
$96M
Market cap
-
P/E ratio
-$0.55
EPS
2.36
Beta
-
Dividend rate
$96M
2.36
6.07
5.942
-203.535
-203.535
-2.65%
-37.50%
365.97%
9.689
-4.08
-4.08
-3.997
758.94%
-4.13%
30.18%
6.43%

What the Analysts think about CLSD

Analyst Ratings

Majority rating from 6 analysts.
Buy

CLSD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-5,850.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$200K
-96.83%
Net income
-$12M
143.75%
Profit margin
-5,850.00%
7,578.17%

CLSD Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 23.55%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.15
-$0.15
-$0.08
-$0.17
-
Expected
-$0.14
-$0.16
-$0.09
-$0.14
-$0.14
Surprise
5.88%
-3.23%
-8.57%
23.55%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Clearside Biomedical stock?

Clearside Biomedical (CLSD) has a market cap of $96M as of July 06, 2024.

What is the P/E ratio for Clearside Biomedical stock?

The price to earnings (P/E) ratio for Clearside Biomedical (CLSD) stock is 0 as of July 06, 2024.

Does Clearside Biomedical stock pay dividends?

No, Clearside Biomedical (CLSD) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Clearside Biomedical dividend payment date?

Clearside Biomedical (CLSD) stock does not pay dividends to its shareholders.

What is the beta indicator for Clearside Biomedical?

Clearside Biomedical (CLSD) has a beta rating of 2.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Clearside Biomedical stock

Buy or sell Clearside Biomedical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing